UNSPSC 51203104: Voclosporin

This classification denotes an immunosuppressant with the molecular formula C63H111N11O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2PN063X6B1, chemically known as (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhepta-4,6-dienyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone but more generally known as voclosporin, which bears US NIH Compound Identifier 6918486.

UNSPSC 51203104 Voclosporin is a Commodity code for a specific immunosuppressant pharmaceutical product, though the recent state and local contract activity posted under this code does not reflect procurement of voclosporin itself. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium in August 2026 for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and Seminole County, Florida issued an IFB in June 2026 for Naloxone and drug deactivation systems — neither aligned with the voclosporin product category. State and local government procurement tagged under this code appears to reflect broader pharmaceutical and medical supply purchasing through cooperative purchasing vehicles such as MMCAP Infuse, with issuing bodies including state health departments and county health agencies sourcing drugs and medical devices for community health and emergency response programs.

Recent activity centers on Florida and Illinois. The Illinois Department of Public Health's contract with Chartwell Rx LLC, valued at $2.99 million over the full contract term including renewals, represents a 12-month initial term with two renewal options and a typical cooperative purchasing piggyback structure. Seminole County's Naloxone procurement called for 1,900 units annually with quarterly deliveries to its Community Health Building in Sanford, under an IFB process with a July 26, 2023 response deadline (note: this posting shows a prior-year deadline despite a June 2026 posting date, suggesting a historical notice). The mismatch between the voclosporin commodity code and the actual pharmaceutical products being solicited signals that this code may see limited direct voclosporin procurement through state and local channels, or that recent opportunities have been tagged inconsistently.